Finance

Lists
Why is NH down 2,50%?
Dive Deeper
NH:NSE
Narayana Hrudayalaya Ltd
1 680,20 INR
-2,50%
(-43,00) 1D
8 ოქტ, 15:30:03 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NH...
Open
1 726,00 INR
High
1 729,20 INR
Low
1 680,20 INR
Mkt. cap
344,66 მლრ.
Avg. vol.
219,08 ათ.
Volume
176,34 ათ.
Dividend
0,27%
Quarterly dividend
1,13 INR
Ex-dividend date
17 ივლ. 2026
P/E ratio
41,77
52-wk high
2 093,30 INR
52-wk low
1 589,00 INR
EPS
40,22 INR
Shares outstanding
204,36 მლნ.
No. of employees
11 ათ.
Open
1 726,00 INR
High
1 729,20 INR
Low
1 680,20 INR
Mkt. cap
344,66 მლრ.
Avg. vol.
219,08 ათ.
Volume
176,34 ათ.
Dividend
0,27%
Quarterly dividend
1,13 INR
Ex-dividend date
17 ივლ. 2026
P/E ratio
41,77
52-wk high
2 093,30 INR
52-wk low
1 589,00 INR
EPS
40,22 INR
Shares outstanding
204,36 მლნ.
No. of employees
11 ათ.
News stories
From web sources and news partners
Profile
Narayana Health is an Indian for-profit private hospital network headquartered in Bangalore. It was founded by Dr. Devi Shetty in the year 2000. It operates several hospitals and heart centres across major Indian cities Bangalore, Delhi, Gurugram, Kolkata, Ahmedabad, Raipur, Jaipur, Mumbai, Mysore etc. with an international subsidiary in the Cayman Islands. The facilities offer medical care in over 30 medical specialties and three of its hospitals – Narayana Institute of Cardiac Sciences, Bangalore, and Health City Cayman Islands – are JCI accredited. Wikipedia
About Narayana Hrudayalaya Ltd
CEOემანუელ რუპერტ
Employees11,2 ათ.
Founded2000
Headquartersბენგალურუ, კარნატაკა, ინდოეთი
SectorHealth care provider
Websitenarayanahealth.org
Last report
3 აგვ. 2026
Fiscal period
Q1 2027
10,20 INR / 11,93 INR
-14,53%miss
Revenue / Est. (INR)
26,84 მლრდ. / 26,38 მლრდ.
+1,74%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
16,44 მლრდ.
21,51 მლრდ.
25,94 მლრდ.
26,84 მლრდ.
Cost of goods sold
8,76 მლრდ.
11,99 მლრდ.
18,24 მლრდ.
15,66 მლრდ.
Cost of revenue
8,76 მლრდ.
11,99 მლრდ.
18,24 მლრდ.
15,66 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
2,56 მლრდ.
-
Operating expense
4,53 მლრდ.
7,07 მლრდ.
4,14 მლრდ.
8,04 მლრდ.
Total operating expenses
13,29 მლრდ.
19,06 მლრდ.
22,38 მლრდ.
23,70 მლრდ.
Operating income
3,15 მლრდ.
2,45 მლრდ.
3,56 მლრდ.
3,14 მლრდ.
Other non operating income
239,92 მლნ.
232,06 მლნ.
-498,95 მლნ.
354,76 მლნ.
EBT including unusual items
2,95 მლრდ.
1,50 მლრდ.
2,92 მლრდ.
2,60 მლრდ.
EBT excluding unusual items
2,95 მლრდ.
2,01 მლრდ.
2,80 მლრდ.
2,60 მლრდ.
Income tax expense
371,93 მლნ.
222,70 მლნ.
641,07 მლნ.
531,19 მლნ.
Effective tax rate
12,59%
14,81%
21,94%
20,40%
Other operating expenses
3,65 მლრდ.
5,85 მლრდ.
38,10 მლნ.
6,48 მლრდ.
Net income
2,58 მლრდ.
1,27 მლრდ.
2,24 მლრდ.
2,07 მლრდ.
Net profit margin
15,72%
5,89%
8,63%
7,72%
Earnings per share
12,71
8,45
11,22
10,20
Interest and investment income
-
-
594,31 მლნ.
-
Interest expense
-422,60 მლნ.
-650,33 მლნ.
-912,85 მლნ.
-868,01 მლნ.
Net interest expenses
-422,60 მლნ.
-650,33 მლნ.
-318,54 მლნ.
-868,01 მლნ.
Depreciation and amortization charges
874,76 მლნ.
1,22 მლრდ.
1,54 მლრდ.
1,56 მლრდ.
EBITDA
4,01 მლრდ.
3,01 მლრდ.
4,45 მლრდ.
4,03 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები